dihydroartemisinin-piperaquine
Selected indexed studies
- Dihydroartemisinin-Piperaquine Combination in the Treatment of Uncomplicated Plasmodium falciparum Malaria: Update on Clinical Failures in Africa and Tools for Surveillance. (J Clin Med, 2024) [PMID:39597971]
- Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria. (Drugs, 2012) [PMID:22515619]
- Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana. (Front Cell Infect Microbiol, 2022) [PMID:36683700]
_Worker-drafted node — pending editorial review._
Connections
dihydroartemisinin-piperaquine is a side effect of
Sources
- Dihydroartemisinin-piperaquine plus sulfadoxine-pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from Uganda. (2025) pubmed
- Dihydroartemisinin-Piperaquine Combination in the Treatment of Uncomplicated Plasmodium falciparum Malaria: Update on Clinical Failures in Africa and Tools for Surveillance. (2024) pubmed
- Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria. (2012) pubmed
- Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana. (2022) pubmed
- Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. (2014) pubmed
- Safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials. (2022) pubmed
- Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials. (2021) pubmed
- Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. (2016) pubmed
- Efficacy of dihydroartemisinin/piperaquine in patients with non-complicated Plasmodium falciparum malaria in Yaoundé, Cameroon. (2021) pubmed
- Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis. (2025) pubmed